The global market for Pharmaceutical Grade Nicotinamide Mononucleotide was valued at US$ 392 million in the year 2024 and is projected to reach a revised size of US$ 962 million by 2031, growing at a CAGR of 13.2% during the forecast period.

Pharmaceutical Grade Nicotinamide Mononucleotide Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Grade Nicotinamide Mononucleotide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Pharmaceutical Grade nicotinamide mononucleotide (NMN) is the part of the NMN market that treats NMN as a dietary ingredient for everyday people, not as a prescription drug or a cosmetic raw material. The molecule itself is the same NMN used in other contexts: a derivative of vitamin B3 and a direct precursor to NAD⁺, a coenzyme that cells need for energy production, DNA repair and many protective processes. Scientific reviews describe NMN as a naturally occurring compound in the body and in small amounts in foods, and explain that boosting NAD⁺ with NMN can influence aging processes in cells and animals. When we say “Pharmaceutical Grade”, we usually mean NMN that is made for oral use under dietary supplement or functional food rules, with high but not necessarily pharmaceutical-level purity, and sold as capsules, powders, drinks or gummies for “healthy aging”, “energy” or “metabolic support”.

From a market definition point of view, Pharmaceutical Grade NMN sits inside the broader nutraceutical and functional food sector. It is positioned as a premium ingredient for people who are not sick enough to need a drug, but who want to age more slowly, feel more energetic, or look after their long-term health. Typical products contain a few hundred milligrams of NMN per daily serving, sometimes combined with other ingredients such as resveratrol, quercetin or coenzyme Q10. Brands use language like “NAD⁺ booster”, “cellular energy”, “mitochondrial support”, and “longevity supplement” to describe the role of NMN. This positioning is grounded in human studies showing that oral NMN can safely raise blood NAD⁺ levels in adults and is generally well tolerated in doses up to around 900–1,250 mg per day over several weeks. These data give supplement makers a scientific story they can link to everyday benefits like vitality, performance and resilience.

In 2024, global Pharmaceutical Grade Nicotinamide Mononucleotide production reached approximately 181.2 MT, with an average global market price of around US$ 2,166 per kg. The global single-line production capacity ranges from 10 to 20 MT per year. The industry's gross profit margin is approximately 30%-50%.

The main drivers for Pharmaceutical Grade NMN can be summarized in simple terms. First, populations in many countries are aging, and chronic diseases such as diabetes, cardiovascular disease and neurodegeneration are increasing. People and health systems are searching for ways to keep individuals healthier for longer, and NAD⁺-related strategies like NMN supplements naturally fit into these conversations. Second, the cultural shift toward self-managed, science-inspired wellness keeps NMN in the spotlight, especially when media and influencers discuss new studies. Third, regulatory clarification in key markets like Japan, Canada and now the United States removes legal uncertainty and encourages investment in new products, supply chains and clinical studies. Fourth, improvements in production technology and rising quality expectations push the market toward better, more consistent Pharmaceutical Grade material.

The Pharmaceutical Grade NMN market can be defined as the global business of producing, formulating and selling NMN as a high-purity dietary ingredient for everyday use, under food and supplement regulations rather than drug law. It is based on a solid but still incomplete scientific foundation around NAD⁺ and aging, and it is strongly influenced by regulatory decisions, consumer trends, quality problems and manufacturing advances. The main trends point toward wider acceptance, more products and more competition, but also toward stricter quality control and more realistic claims. How the market develops over the next decade will depend on the balance between hopeful early data and the harder evidence that will come from larger, longer human studies, as well as on how responsibly companies handle this powerful but still not fully understood molecule.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Nicotinamide Mononucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Nicotinamide Mononucleotide.

The Pharmaceutical Grade Nicotinamide Mononucleotide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Nicotinamide Mononucleotide market comprehensively. Regional market sizes, concerning products by Type, by Application, by Production Method and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical Grade Nicotinamide Mononucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Production Method and by regions.

Scope of Pharmaceutical Grade Nicotinamide Mononucleotide Market Report

Report Metric	Details
Report Name	Pharmaceutical Grade Nicotinamide Mononucleotide Market
Accounted market size in year	US$ 392 million
Forecasted market size in 2031	US$ 962 million
CAGR	13.2%
Base Year	year
Forecasted years	2026 - 2031
Segment by Type	Concentration≥98% Concentration＜98%
Segment by Production Method	Enzymatic Synthesis Chemical Synthesis
Segment by Sales Channel	Direct-to-consumer Online Offline Retail Professional Channel
Segment by Application	Health Products Others
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GeneHarbor, Herbalmax, Genex Formulas, EffePharm, Mirailab Bioscience, Bontac Bio-Engineering, Kingdomway, Maac10 Formulas, CELFULL, ABA Chemical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, by Production Method etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Grade Nicotinamide Mononucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Grade Nicotinamide Mononucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Grade Nicotinamide Mononucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Grade Nicotinamide Mononucleotide Market growing?

Ans: The Pharmaceutical Grade Nicotinamide Mononucleotide Market witnessing a CAGR of 13.2% during the forecast period 2026-2031.

What is the Pharmaceutical Grade Nicotinamide Mononucleotide Market size in 2031?

Ans: The Pharmaceutical Grade Nicotinamide Mononucleotide Market size in 2031 will be US$ 962 million.

Who are the main players in the Pharmaceutical Grade Nicotinamide Mononucleotide Market report?

Ans: The main players in the Pharmaceutical Grade Nicotinamide Mononucleotide Market are GeneHarbor, Herbalmax, Genex Formulas, EffePharm, Mirailab Bioscience, Bontac Bio-Engineering, Kingdomway, Maac10 Formulas, CELFULL, ABA Chemical

What are the Application segmentation covered in the Pharmaceutical Grade Nicotinamide Mononucleotide Market report?

Ans: The Applications covered in the Pharmaceutical Grade Nicotinamide Mononucleotide Market report are Health Products, Others

What are the Type segmentation covered in the Pharmaceutical Grade Nicotinamide Mononucleotide Market report?

Ans: The Types covered in the Pharmaceutical Grade Nicotinamide Mononucleotide Market report are Concentration≥98%, Concentration＜98%

1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Overview

1.1 Product Definition

1.2 Pharmaceutical Grade Nicotinamide Mononucleotide by Type

1.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Type: 2024 VS 2031

1.2.2 Concentration≥98%

1.2.3 Concentration＜98%

1.3 Pharmaceutical Grade Nicotinamide Mononucleotide by Production Method

1.3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Production Method: 2024 VS 2031

1.3.2 Enzymatic Synthesis

1.3.3 Chemical Synthesis

1.4 Pharmaceutical Grade Nicotinamide Mononucleotide by Sales Channel

1.4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Sales Channel: 2024 VS 2031

1.4.2 Direct-to-consumer Online

1.4.3 Offline Retail

1.4.4 Professional Channel

1.5 Pharmaceutical Grade Nicotinamide Mononucleotide by Application

1.5.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Application: 2024 VS 2031

1.5.2 Health Products

1.5.3 Others

1.6 Global Market Growth Prospects

1.6.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)

1.6.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity Estimates and Forecasts (2020-2031)

1.6.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Estimates and Forecasts (2020-2031)

1.6.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price Estimates and Forecasts (2020-2031)

1.7 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Manufacturers (2020-2025)

2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Manufacturers (2020-2025)

2.3 Global Key Players of Pharmaceutical Grade Nicotinamide Mononucleotide, Industry Ranking, 2023 VS 2024

2.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.5 Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (2020-2025)

2.6 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Manufacturing Base Distribution and Headquarters

2.7 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Product Offered and Application

2.8 Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Date of Enter into This Industry

2.9 Pharmaceutical Grade Nicotinamide Mononucleotide Market Competitive Situation and Trends

2.9.1 Pharmaceutical Grade Nicotinamide Mononucleotide Market Concentration Rate

2.9.2 Global 5 and 10 Largest Pharmaceutical Grade Nicotinamide Mononucleotide Players Market Share by Revenue

2.10 Mergers & Acquisitions, Expansion

3 Pharmaceutical Grade Nicotinamide Mononucleotide Production by Region

3.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region (2020-2031)

3.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region (2020-2025)

3.2.2 Global Forecasted Production Value of Pharmaceutical Grade Nicotinamide Mononucleotide by Region (2026-2031)

3.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

3.4 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Volume by Region (2020-2031)

3.4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Region (2020-2025)

3.4.2 Global Forecasted Production of Pharmaceutical Grade Nicotinamide Mononucleotide by Region (2026-2031)

3.5 Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Price Analysis by Region (2020-2025)

3.6 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production and Value, Year-over-Year Growth

3.6.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)

3.6.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)

3.6.3 China Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)

3.6.4 Japan Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2020-2031)

4 Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region

4.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031

4.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2031)

4.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2025)

4.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption by Region (2026-2031)

4.3 North America

4.3.1 North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.3.2 North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2031)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.4.2 Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2031)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031

4.5.2 Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2031)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031

4.6.2 Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2031)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2020-2031)

5.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2020-2025)

5.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Type (2026-2031)

5.1.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2020-2031)

5.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2020-2031)

5.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2020-2025)

5.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Type (2026-2031)

5.2.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Type (2020-2031)

5.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Type (2020-2031)

6 Segment by Application

6.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2020-2031)

6.1.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2020-2025)

6.1.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Application (2026-2031)

6.1.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2020-2031)

6.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2020-2031)

6.2.1 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2020-2025)

6.2.2 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Application (2026-2031)

6.2.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Application (2020-2031)

6.3 Global Pharmaceutical Grade Nicotinamide Mononucleotide Price by Application (2020-2031)

7 Key Companies Profiled

7.1 GeneHarbor

7.1.1 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.1.2 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.1.3 GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.1.4 GeneHarbor Main Business and Markets Served

7.1.5 GeneHarbor Recent Developments/Updates

7.2 Herbalmax

7.2.1 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.2.2 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.2.3 Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.2.4 Herbalmax Main Business and Markets Served

7.2.5 Herbalmax Recent Developments/Updates

7.3 Genex Formulas

7.3.1 Genex Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.3.2 Genex Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.3.3 Genex Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.3.4 Genex Formulas Main Business and Markets Served

7.3.5 Genex Formulas Recent Developments/Updates

7.4 EffePharm

7.4.1 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.4.2 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.4.3 EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.4.4 EffePharm Main Business and Markets Served

7.4.5 EffePharm Recent Developments/Updates

7.5 Mirailab Bioscience

7.5.1 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.5.2 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.5.3 Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.5.4 Mirailab Bioscience Main Business and Markets Served

7.5.5 Mirailab Bioscience Recent Developments/Updates

7.6 Bontac Bio-Engineering

7.6.1 Bontac Bio-Engineering Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.6.2 Bontac Bio-Engineering Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.6.3 Bontac Bio-Engineering Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.6.4 Bontac Bio-Engineering Main Business and Markets Served

7.6.5 Bontac Bio-Engineering Recent Developments/Updates

7.7 Kingdomway

7.7.1 Kingdomway Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.7.2 Kingdomway Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.7.3 Kingdomway Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.7.4 Kingdomway Main Business and Markets Served

7.7.5 Kingdomway Recent Developments/Updates

7.8 Maac10 Formulas

7.8.1 Maac10 Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.8.2 Maac10 Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.8.3 Maac10 Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.8.4 Maac10 Formulas Main Business and Markets Served

7.8.5 Maac10 Formulas Recent Developments/Updates

7.9 CELFULL

7.9.1 CELFULL Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.9.2 CELFULL Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.9.3 CELFULL Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.9.4 CELFULL Main Business and Markets Served

7.9.5 CELFULL Recent Developments/Updates

7.10 ABA Chemical

7.10.1 ABA Chemical Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

7.10.2 ABA Chemical Pharmaceutical Grade Nicotinamide Mononucleotide Product Portfolio

7.10.3 ABA Chemical Pharmaceutical Grade Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2020-2025)

7.10.4 ABA Chemical Main Business and Markets Served

7.10.5 ABA Chemical Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Chain Analysis

8.2 Pharmaceutical Grade Nicotinamide Mononucleotide Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Pharmaceutical Grade Nicotinamide Mononucleotide Production Mode & Process Analysis

8.4 Pharmaceutical Grade Nicotinamide Mononucleotide Sales and Marketing

8.4.1 Pharmaceutical Grade Nicotinamide Mononucleotide Sales Channels

8.4.2 Pharmaceutical Grade Nicotinamide Mononucleotide Distributors

8.5 Pharmaceutical Grade Nicotinamide Mononucleotide Customer Analysis

9 Pharmaceutical Grade Nicotinamide Mononucleotide Market Dynamics

9.1 Pharmaceutical Grade Nicotinamide Mononucleotide Industry Trends

9.2 Pharmaceutical Grade Nicotinamide Mononucleotide Market Drivers

9.3 Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges

9.4 Pharmaceutical Grade Nicotinamide Mononucleotide Market Restraints

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

Bontac Bio-engineering

List of Tables

Table 1. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Type, (US$ Million) & (2024 VS 2031)

Table 2. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Production Method, (US$ Million) & (2024 VS 2031)

Table 3. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Sales Channel, (US$ Million) & (2024 VS 2031)

Table 4. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2024 VS 2031)

Table 5. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity (Tons) by Manufacturers in 2024

Table 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production by Manufacturers (2020-2025) & (Tons)

Table 7. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Manufacturers (2020-2025)

Table 8. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Manufacturers (2020-2025) & (US$ Million)

Table 9. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Manufacturers (2020-2025)

Table 10. Global Key Players of Pharmaceutical Grade Nicotinamide Mononucleotide, Industry Ranking, 2023 VS 2024

Table 11. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pharmaceutical Grade Nicotinamide Mononucleotide as of 2024)

Table 12. Global Market Pharmaceutical Grade Nicotinamide Mononucleotide Average Price by Manufacturers (US$/Kg) & (2020-2025)

Table 13. Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Manufacturing Base Distribution and Headquarters

Table 14. Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Product Offered and Application

Table 15. Global Key Manufacturers of Pharmaceutical Grade Nicotinamide Mononucleotide, Date of Enter into This Industry

Table 16. Global Pharmaceutical Grade Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Mergers & Acquisitions, Expansion Plans

Table 18. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Region (2020-2025)

Table 20. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Region (2020-2025)

Table 21. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Forecast by Region (2026-2031)

Table 22. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share Forecast by Region (2026-2031)

Table 23. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Table 24. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Region (2020-2025)

Table 25. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Region (2020-2025)

Table 26. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) Forecast by Region (2026-2031)

Table 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share Forecast by Region (2026-2031)

Table 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price (US$/Kg) by Region (2020-2025)

Table 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Average Price (US$/Kg) by Region (2026-2031)

Table 30. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 31. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2025) & (Tons)

Table 32. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Region (2020-2025)

Table 33. Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption by Region (2026-2031) & (Tons)

Table 34. Global Pharmaceutical Grade Nicotinamide Mononucleotide Forecasted Consumption Market Share by Region (2026-2031)

Table 35. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 36. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2025) & (Tons)

Table 37. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2026-2031) & (Tons)

Table 38. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 39. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2025) & (Tons)

Table 40. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2026-2031) & (Tons)

Table 41. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)

Table 42. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2020-2025) & (Tons)

Table 43. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region (2026-2031) & (Tons)

Table 44. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)

Table 45. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2020-2025) & (Tons)

Table 46. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Country (2026-2031) & (Tons)

Table 47. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Type (2020-2025)

Table 48. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Type (2026-2031)

Table 49. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2020-2025)

Table 50. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Type (2026-2031)

Table 51. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Type (2020-2025)

Table 52. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Type (2026-2031)

Table 53. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Type (2020-2025)

Table 54. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Type (2026-2031)

Table 55. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Kg) by Type (2020-2025)

Table 56. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Kg) by Type (2026-2031)

Table 57. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Application (2020-2025)

Table 58. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) by Application (2026-2031)

Table 59. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2020-2025)

Table 60. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Application (2026-2031)

Table 61. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2020-2025)

Table 62. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2026-2031)

Table 63. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Application (2020-2025)

Table 64. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Application (2026-2031)

Table 65. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Kg) by Application (2020-2025)

Table 66. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Kg) by Application (2026-2031)

Table 67. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 68. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 69. GeneHarbor Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 70. GeneHarbor Main Business and Markets Served

Table 71. GeneHarbor Recent Developments/Updates

Table 72. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 73. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 74. Herbalmax Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 75. Herbalmax Main Business and Markets Served

Table 76. Herbalmax Recent Developments/Updates

Table 77. Genex Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 78. Genex Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 79. Genex Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 80. Genex Formulas Main Business and Markets Served

Table 81. Genex Formulas Recent Developments/Updates

Table 82. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 83. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 84. EffePharm Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 85. EffePharm Main Business and Markets Served

Table 86. EffePharm Recent Developments/Updates

Table 87. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 88. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 89. Mirailab Bioscience Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 90. Mirailab Bioscience Main Business and Markets Served

Table 91. Mirailab Bioscience Recent Developments/Updates

Table 92. Bontac Bio-Engineering Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 93. Bontac Bio-Engineering Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 94. Bontac Bio-Engineering Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 95. Bontac Bio-Engineering Main Business and Markets Served

Table 96. Bontac Bio-Engineering Recent Developments/Updates

Table 97. Kingdomway Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 98. Kingdomway Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 99. Kingdomway Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 100. Kingdomway Main Business and Markets Served

Table 101. Kingdomway Recent Developments/Updates

Table 102. Maac10 Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 103. Maac10 Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 104. Maac10 Formulas Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 105. Maac10 Formulas Main Business and Markets Served

Table 106. Maac10 Formulas Recent Developments/Updates

Table 107. CELFULL Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 108. CELFULL Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 109. CELFULL Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 110. CELFULL Main Business and Markets Served

Table 111. CELFULL Recent Developments/Updates

Table 112. ABA Chemical Pharmaceutical Grade Nicotinamide Mononucleotide Company Information

Table 113. ABA Chemical Pharmaceutical Grade Nicotinamide Mononucleotide Specification and Application

Table 114. ABA Chemical Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 115. ABA Chemical Main Business and Markets Served

Table 116. ABA Chemical Recent Developments/Updates

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Pharmaceutical Grade Nicotinamide Mononucleotide Distributors List

Table 120. Pharmaceutical Grade Nicotinamide Mononucleotide Customers List

Table 121. Pharmaceutical Grade Nicotinamide Mononucleotide Market Trends

Table 122. Pharmaceutical Grade Nicotinamide Mononucleotide Market Drivers

Table 123. Pharmaceutical Grade Nicotinamide Mononucleotide Market Challenges

Table 124. Pharmaceutical Grade Nicotinamide Mononucleotide Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

Table 128. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pharmaceutical Grade Nicotinamide Mononucleotide

Figure 2. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Type, (US$ Million) & (2020-2031)

Figure 3. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Type: 2024 VS 2031

Figure 4. Concentration≥98% Product Picture

Figure 5. Concentration＜98% Product Picture

Figure 6. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Production Method, (US$ Million) & (2020-2031)

Figure 7. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Production Method: 2024 VS 2031

Figure 8. Enzymatic Synthesis Product Picture

Figure 9. Chemical Synthesis Product Picture

Figure 10. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Sales Channel, (US$ Million) & (2020-2031)

Figure 11. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Sales Channel: 2024 VS 2031

Figure 12. Direct-to-consumer Online Product Picture

Figure 13. Offline Retail Product Picture

Figure 14. Professional Channel Product Picture

Figure 15. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2020-2031)

Figure 16. Global Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Application: 2024 VS 2031

Figure 17. Application One

Figure 18. Application Two

Figure 19. Application Three

Figure 20. Application Four

Figure 21. Application Five

Figure 22. Application Six

Figure 23. Application Seven

Figure 24. Application Eight

Figure 25. Application Nine

Figure 26. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million), 2020 VS 2024 VS 2031

Figure 27. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) & (2020-2031)

Figure 28. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Capacity (Tons) & (2020-2031)

Figure 29. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production (Tons) & (2020-2031)

Figure 30. Global Pharmaceutical Grade Nicotinamide Mononucleotide Average Price (US$/Kg) & (2020-2031)

Figure 31. Pharmaceutical Grade Nicotinamide Mononucleotide Report Years Considered

Figure 32. Pharmaceutical Grade Nicotinamide Mononucleotide Production Share by Manufacturers in 2024

Figure 33. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Share by Manufacturers (2024)

Figure 34. Pharmaceutical Grade Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 35. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Grade Nicotinamide Mononucleotide Revenue in 2024

Figure 36. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 37. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Value Market Share by Region: 2020 VS 2024 VS 2031

Figure 38. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 39. Global Pharmaceutical Grade Nicotinamide Mononucleotide Production Market Share by Region: 2020 VS 2024 VS 2031

Figure 40. North America Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2020-2031)

Figure 41. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2020-2031)

Figure 42. China Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2020-2031)

Figure 43. Japan Pharmaceutical Grade Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2020-2031)

Figure 44. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption by Region: 2020 VS 2024 VS 2031 (Tons)

Figure 45. Global Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Region: 2020 VS 2024 VS 2031

Figure 46. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 47. North America Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2020-2031)

Figure 48. U.S. Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 49. Canada Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 50. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 51. Europe Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2020-2031)

Figure 52. Germany Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 53. France Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 54. U.K. Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 55. Italy Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 56. Russia Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 57. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 58. Asia Pacific Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Region (2020-2031)

Figure 59. China Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 60. Japan Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 61. South Korea Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 62. China Taiwan Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 63. Southeast Asia Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 64. India Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 65. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 66. Latin America, Middle East & Africa Pharmaceutical Grade Nicotinamide Mononucleotide Consumption Market Share by Country (2020-2031)

Figure 67. Mexico Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 68. Brazil Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 69. Turkey Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 70. GCC Countries Pharmaceutical Grade Nicotinamide Mononucleotide Consumption and Growth Rate (2020-2031) & (Tons)

Figure 71. Global Production Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2020-2031)

Figure 72. Global Production Value Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Type (2020-2031)

Figure 73. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Kg) by Type (2020-2031)

Figure 74. Global Production Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Application (2020-2031)

Figure 75. Global Production Value Market Share of Pharmaceutical Grade Nicotinamide Mononucleotide by Application (2020-2031)

Figure 76. Global Pharmaceutical Grade Nicotinamide Mononucleotide Price (US$/Kg) by Application (2020-2031)

Figure 77. Pharmaceutical Grade Nicotinamide Mononucleotide Value Chain

Figure 78. Channels of Distribution (Direct Vs Distribution)

Figure 79. Bottom-up and Top-down Approaches for This Report

Figure 80. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Beta Nicotinamide Mononucleotide NMN Market Research Report 2025

Global β Nicotinamide Mononucleotide NMN Market Research Report 2025

Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Research Report 2025

Global NMN Raw Materials Market Research Report 2025

Global Nicotinamide Adenine Dinucleotide NAD Market Insights Forecast to 2030

Global NAD Enhancer Market Research Report 2025

Global NMN Health Supplement Market Research Report 2024

β Nicotinamide Mononucleotide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global NAD Booster Market Research Report 2024

Global β NMN Supplements Market Research Report 2024

Global NMN Capsule Market Research Report 2024

Global Nicotinamide Mononucleotide Supplement Market Research Report 2025

Global NAD Booster Capsule Market Research Report 2024

Global NAD Anti Aging Products Market Research Report 2024

Global Cosmetic Grade Nicotinamide Mononucleotide Market Research Report 2025

Global Beta Nicotinamide Mononucleotide Market Research Report 2024

Global Nicotinamide Ribose NR Market Insights Forecast to 2030

Global NAD Anti Aging Nutraceuticals Market Research Report 2024

Global NAD Supplements Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions